1. Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, Paulshock M, Watts JC, Wood TR, Hermann EC, Hoffman CE. Antiviral activity of 1-adamantanamine (Amantadine). Science 1964; 144: 862–863
2. Tsunoda A, Maasab HF, Cochran KW, Eveland WC. Antiviral activity of α-methyl-1-adamantanemethylamine hydrochloride. Antimicrob. Agents Chemother. 1965; 5: 553–560
3. Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infections. N. Engl. J. Med. 1982; 307: 580–584
4. Hayden FG. Amantadine and rimantadine: efficacy, side effects, pharmokinetics. J. Resp. Dis. 1987; 6(Suppl): S45–S50
5. Aldrich PE, Herman EC, Meier WE, Paulshock M, Prichard WW, Snyder JA, Watts JC. Antiviral agents 2. Structure-activity relationships of compounds related to adamantanamine. J. Med. Chem. 1971; 14: 535–543